- Home
- Latest
- By speciality
- Policy
- Biology
- Bone
- Brain and nervous system
- Breast
- Colorectal and gastrointestinal
- Community
- Diagnostics
- Drug development
- Epidemiology and prevention
- Haematology oncology
- Head and neck
- Hepatobiliary pancreatic
- Lung and pleura
- Melanoma and skin
- Ovary and gynaecology
- Paediatric
- Prostate and urology
- Psycho social
- Radiotherapy
- Sarcomas
- Surgery
- Other
- By congress
- By continent
- Latest technologies
- Education
- Most viewed
- View all
ASH 50th annual meeting 2008, Drug development, Drugs in development, Haematology oncol...
Flash player required
You do not have the correct version of the flash player required to view this content. Click here to install the free Adobe flash player.
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Effects of Myelodysplastic Syndrome
How MDS affects patients' lives, other treatment options for MDS, repeated blood transfusions and how Vidaza/Azacitidine helps reduce transfusion dependence. Speaking at ASH 2008.
Technologies » Targeted molecules
Content is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
Comments on this video Report unsuitable comment
No comments have been made on this video yet, be the first to voice your opinion, use the form on the right.
Add a comment